VDR - vitamin D receptor Gene
Also Known as NR1I1
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 396628
About VDR
Primary_assembly 5: 78,205,810-78,266,475 reverse strand.Sscrofa11.1:CM000816.5
This gene has 1 transcript (splice variant), 462 orthologues and 18 paralogues. Biased expression in kidney (RPKM 13.6), mixtures (RPKM 2.5) and 3 other tissues.
VDR Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001097414.1 | NP_001090883.1 | vitamin D3 receptor |
VDR Protein Structure
NR_DBD_VDR
NR_DBD_VDR: cd06955 (15 - 121)
NR_LBD
NR_LBD: cl11397 (123 - 311)
- 0
- 100
- 200
- 300
- 400
- 442 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
vitamin D3 receptor |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-10002 | Calcitriol | Agonist | 99.94% | Unkown |
| HY-32351 | Calcifediol | 99.94% | Unkown | |
| HY-10003 | Alfacalcidol | Activator | 99.96% | Unkown |
| HY-32339 | Maxacalcitol | Activator | 99.71% | Unkown |
| HY-32351A | Calcifediol monohydrate | 99.98% | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Phase
|
|---|---|---|---|---|
| HY-32344 | Inecalcitol | 98.44% | Phase 2 | |
| HY-32345 | Elocalcitol | 99.2% | Phase 2 | |
| HY-14863 | Lunacalcipol | / | Phase 2 | |
| HY-32351S3 | Calcifediol-d9 | / | Phase 2 | |
| HY-B1844 | Flucythrinate | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(60)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-147337 | MeTC7 | Antagonist | 98.50% | Unkown |
| HY-32343 | Secalciferol | Activator | 99.85% | Unkown |
| HY-12407 | ZK168281 | Antagonist | 98.0% | Unkown |
| HY-76814 | Calcitriol-d6 | Activator | 99.27% | Unkown |
| HY-32350 | Ercalcitriol | Activator | 99.71% | Unkown |
| HY-13332 | Calcifediol-d6 | Activator | 99.09% | Unkown |
| HY-12398 | TEI-9647 | Agonist | 99.10% | Unkown |
| HY-103053 | PS121912 | Inhibitor | 96.40% | Unkown |
| HY-10002A | (1S)-Calcitriol | 98.52% | Unkown | |
| HY-12397 | ZK159222 | Antagonist | 99.23% | Unkown |
| HY-12398A | TEI-9648 | Inhibitor | 99.24% | Unkown |
| HY-77278 | 25-Hydroxytachysterol3 | Agonist | 98.07% | Unkown |
| HY-15329 | Maxacalcitol-d6 | Activator | 96.03% | Unkown |
| HY-32351S | Calcifediol-d3 | 98.96% | Unkown | |
| HY-131492 | Δ4-Dafachronic acid | Ligand | 96.93% | Unkown |
| HY-RS15632 | VDR Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-131961 | Triciferol | 98.61% | Unkown | |
| HY-N10508 | Calcitroic acid | Agonist | 85.0% | Unkown |
| HY-13294 | Impurity C of Alfacalcidol | Activator | 99.81% | Unkown |
| HY-15332 | Alfacalcidol-d6 | Activator | 98.0% | Unkown |
| HY-32351AS | Calcifediol-d6 monohydrate | 97.50% | Unkown | |
| HY-13293 | Impurity C of Calcitriol | Activator | 99.84% | Unkown |
| HY-RS15633 | Vdr Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-154825 | 20-Hydroxyvitamin D3 | ≥98.0% | Unkown | |
| HY-77274 | Calcitriol Impurities D | Activator | 95.18% | Unkown |
| HY-114310 | VDR agonist 1 | / | Unkown | |
| HY-10002B | (1R,5Z)-Calcitriol | Control | / | Unkown |
| HY-119612 | XCT0135908 | / | Unkown | |
| HY-10002AS | (1S)-Calcitriol-d3 | / | Unkown | |
| HY-10002AS2 | (1S)-Calcitriol-d6 | / | Unkown | |
| HY-10002S1 | Calcitriol-d3 | / | Unkown | |
| HY-10002S2 | Calcitriol-d9 | / | Unkown | |
| HY-10003S | Alfacalcidol-d7 | Activator | / | Unkown |
| HY-117182 | LG190178 | / | Unkown | |
| HY-118970 | LG190155 | / | Unkown | |
| HY-131492S | Δ4-Dafachronic Acid-d3 | Ligand | / | Unkown |
| HY-149899 | VDR agonist 2 | Agonist | / | Unkown |
| HY-15364 | 19-nor-1α,25-Dihydroxyvitamin D3 | Ligand | / | Unkown |
| HY-161778 | ZG-126 | / | Unkown | |
| HY-163947 | UG-480 | Modulator | / | Unkown |
| HY-166525S | 24R-Calcipotriol-d4 | Activator | / | Unkown |
| HY-170975 | UG-650 | Ligand | / | Unkown |
| HY-172087 | VDR agonist 3 | Agonist | / | Unkown |
| HY-173393 | LXRα agonist 1 | Agonist | / | Unkown |
| HY-178328 | VDR agonist 4 | / | Unkown | |
| HY-178336 | AC-340 | / | Unkown | |
| HY-179431 | VDR ligand-1 | Agonist | / | Unkown |
| HY-181486 | VDR agonist 5 | Agonist | / | Unkown |
| HY-182038 | TGF-β1/Smad3-IN-2 | / | Unkown | |
| HY-19380 | Ro-65-2299 | Agonist | / | Unkown |
| HY-32351AS1 | Calcifediol-13C5 monohydrate | / | Unkown | |
| HY-N10508S | Calcitroic acid-13C | / | Unkown | |
| HY-RS03451 | CYP27B1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS15634 | Vdr Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-10002S | Calcitriol-13C3 | Inhibitor | 97.0% | Unkown |
| HY-177795 | 5β-Cholanic acid-3,6-dione | / | Unkown | |
| HY-180503 | 19-Nor-22-oxa-1a,25(OH)2-VD3 | / | Unkown | |
| HY-32350S1 | Ercalcitriol-d3 | Activator | / | Unkown |
| HY-RS16287 | Cyp27b1 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-107218 | 11-Hydroxysugiol | Modulator | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service